1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
(
- Contribution to journal › Article
- 2023
-
Mark
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis
(
- Contribution to journal › Article
- 2022
-
Mark
Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data
(
- Contribution to journal › Article
-
Mark
SRIQ clustering : A fusion of Random Forest, QT clustering, and KNN concepts
(
- Contribution to journal › Article
- 2021
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
(
- Contribution to journal › Article
-
Mark
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
(
- Contribution to journal › Article
- 2020
-
Mark
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer : A Step in the Right Direction but Still a Long Way To Go.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
Methylation patterns and chromatin accessibility in neuroendocrine lung cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Novel genetic loci associated with long-term deterioration in blood lipid concentrations and coronary artery disease in European adults
(
- Contribution to journal › Article